Condition: Non-infected Venous Leg Ulcer · Venous Leg Ulcer · Venous Insufficiency · Sponsor: BioStem Technologies
This study examines a patient population with a non-healing, non-infected venous leg ulcer (VLU) having adequate arterial perfusion with confirmed venous reflux. It is hypothesized that weekly applications of the human placental allograft BioREtain® Amnion Chorion (BR-AC) applied to a non-healing VLU will result in a higher proportion of wounds showing complete healing within 12 weeks of initiating therapy, compared to standard care alone. This study has a crossover period, where subjects on standard care alone who do not achieve complete healing within 12 weeks of initiating therapy will be allowed to crossover to receive BR-AC over 12 additional weeks, to evaluate if their wound can achieve complete healing.
This description comes directly from the study's public registry record.
Nick McCoy · 2144571996 · nmccoy@biostemtech.com
Always discuss trial participation with your own doctor first.
| Site 17 | Guntersville, Alabama, United States | Recruiting |
| Site 2b | Castro Valley, California, United States | Recruiting |
| Site 19b | Glendale, California, United States | Recruiting |
| Site 36 | Oxnard, California, United States | Recruiting |
| Site 37 | Oxnard, California, United States | Recruiting |
| Site 19 | Palmdale, California, United States | Recruiting |
| Site 02 | San Francisco, California, United States | Recruiting |
| Site 2a | San Francisco, California, United States | Recruiting |
| Site 04 | Sylmar, California, United States | Recruiting |
| Site 30 | Torrance, California, United States | Recruiting |
| Site 01 | Vista, California, United States | Recruiting |
| Site 34 | Aventura, Florida, United States | Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06811909